InsidersTradesSigma
Track the Citius Pharmaceuticals, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €18.7m. The latest transaction was filed on 30 August 2024 (Levée d'options). Among the most active insiders: Holuka Eugene Myron. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Citius Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative treatments for serious medical conditions. It is listed on NASDAQ under the ticker CTXR.